Navigation Links
NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
Date:8/27/2007

est from the United States Department of Defense to explore the potential of rapid determination of Anthrax spore viability, utilizing NanoLogix's BioNanoChannel(TM) (BNC) technology. There appears to be an opportunity to determine the viability and persistence of Anthrax spores much faster than current methods due to the unique rapid culturing aspects of the BNC technology. "Superb progress has been made in our research efforts simulating Anthrax spore growth through the use of non-hazardous spores. This research has the potential to immediately translate to the ability to conduct rapid Anthrax viability testing," said CEO Bret Barnhizer. "We have been impressed with the Department of Defense's dedication to finding the best solution for the security of our country in the event of a biological attack. We look forward to making a major contribution in this area by providing a method by which the government is able to determine the effectiveness of their decontamination efforts in hours rather than days."

About NanoLogix, Inc.

NanoLogix is an industry innovator in the research, development, and commercialization of nano-biotechnologies, applications and processes. The Company has developed and owns or has rights to 31 patents related to various medical technologies, 5 of which also have hydrogen-generation aspects. In the past year the Company has filed an additional 28 patent applications for discoveries related to hydrogen bioreactors, medical testing, and innovative medical treatments potentially related to leukemia and sepsis. NanoLogix is presently operating a hydrogen bioreactor at Welch's Food. NanoLogix-developed patents are used to design and market diagnostic test kits for use in early detection of the bacteria present in infectious and noninfectious human diseases such as tuberculosis, pneumonia, HIV/AIDS, cancer, and cystic fibrosis. The company also owns a patent for the non-toxic induction of apoptosis ('cell suicide') for the treatment of c
'/>"/>

SOURCE NanoLogix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sharon Ethanol appoints operations director
2. Kyron appoints former AMA chairman to board
3. Brady appoints GE efficiency expert as CTO
4. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
5. Johnson Controls appoints Roell to head EOC
6. SecurePipe appoints two senior execs
7. Milwaukees PointOne appoints new president and CEO
8. Third Wave appoints new chairman
9. Midwest Venture Summit disappoints; Cato grades Midwest governors
10. Sonic Foundry appoints Engineering Dean and Cometa CEO to Board of Directors
11. TeraMEDICA Appoints Prekop as New President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014 Immunomic Therapeutics, Inc. (ITI) ... further develop potential treatments for glioblastoma multiforme (GBM), the ... with their patented vaccine platform, LAMP-vax. , The ... based on the work of John H. Sampson, MD, ... Preston Robert Tisch Brain Tumor Center at Duke University ...
(Date:7/28/2014)... , July 28, 2014  InterMune, Inc. (NASDAQ: ... its second quarter 2014 financial results at the close ... live conference call and webcast will be hosted by ... Interested investors and others may participate in ... 212-231-2900 (international), conference ID#21728775. A replay of the webcast and ...
(Date:7/25/2014)... "Ischemic Stroke and Cerebral Stroke ... on the Ischemic Stroke and Cerebral Stroke clinical ... data relating to the clinical trials on Ischemic ... Ischemic Stroke Research Report 2014 at: http://www.marketresearchreports.biz/analysis/213207 ... trial numbers and their recruitment status as per ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 According to ... "Biological Drugs Market - Global Industry Analysis, Size, Share, ... biological drugs market is estimated at USD 161,056.5 million ... CAGR of 10.1% from 2014 to 2020, to reach ... , The biological drugs market is witnessing a significant ...
Breaking Biology Technology:String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 2String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 3String of Collaborations Launch Immunomic Therapeutics’ Brain Tumor Program Pipeline 4InterMune to Release Second Quarter Financial Results on August 6 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3
... as I sat at lunch sending off a series of ... how our professional lives continue to evolve dramatically, and in ... of a company that is driving the adoption of Internet ... quickly technological change continues to transform and enhance our professional ...
... action. Lies do not become us." , ,- Dread Pirate ... sometime seem like a big challenge to marketers. They can ... opportunity, however, small business owners can also be timely and ... and growing market to many businesses. According to the ...
... building of a state-of-the-art medical research facility that could ... new drug candidates is being challenged by a vocal ... in Chandler, Ariz., the proposed facility represents the next ... Inc. , following the recent expansion of its facilities ...
Cached Biology Technology:Visions: Rimas Buinevicius, CEO of Sonic Foundry 2Visions: Rimas Buinevicius, CEO of Sonic Foundry 3Big opportunities with small businesses 2Big opportunities with small businesses 3Covance spars with animal rights activists 2Covance spars with animal rights activists 3Covance spars with animal rights activists 4
(Date:7/28/2014)... cities that have seen an increase in so-called "nuisance ... overwhelmed storm drains and compromised infrastructure--are on the East ... This nuisance flooding, caused by rising sea levels, has ... 925 percent since the 1960s. , The report, Sea ... United States, also finds Annapolis and Baltimore, Maryland, lead ...
(Date:7/28/2014)... St. Jude Children,s Research Hospital study found that 73 ... doubled their risk of developing metabolic syndrome and related ... The results appear in the current issue of the ... the 1,598 adult survivors of childhood cancer in the ... risk factors like high blood pressure, abdominal obesity, elevated ...
(Date:7/28/2014)... natural virus killers to prevent and treat HIV infection ... inflammatory response these molecules can arouse as they get ... scientists at the Weizmann Institute and the National Institutes ... of these molecules interferons around the time ... of the disease. Their research appeared in Nature ...
Breaking Biology News(10 mins):NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 2NOAA: 'Nuisance flooding' an increasing problem as coastal sea levels rise 3Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 2Unhealthy habits more than double risk of metabolic syndrome in childhood cancer survivors 3Interfering with interferon 2
... Md., Aug. 31 The Lockheed Martin (NYSE: LMT ... has successfully completed Critical Design Review (CDR) for the system,s fingerprint ... Bureau of Investigation,s (FBI) new multi-modal, state-of-the-art biometrics system. , ... the quantum leap in capability that NGI will deliver as a ...
... chunks of red meat: when wildlife specialists find these ... can now use newly published genetic sequences known as ... hope that this simple technique will track the harvesting ... and Central America, and Africa) and will ultimately crack ...
... matter, has been used by commercial growers and amateur ... is added to potting soil to help retain moisture ... grew, acres of peat bogs were being drained and ... peat from wetlands are mounting. And as peat supplies ...
Cached Biology News:Lockheed Martin Team Completes Key Design Milestone on Federal Bureau of Investigation's Next Generation Identification Program 2The first DNA barcodes of commonly traded bushmeat are published 2The first DNA barcodes of commonly traded bushmeat are published 3For peat's sake: Alternative growing media 2
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
... g. High quality kits and ... that give consistent and reliable ... tissues.Clean up samples from contaminants.Efficiently ... quantitate protein for first-dimension isoelectric ...
... The Varian Cary 50 ... reduces your cost per analysis ... throughput of the award-winning Cary ... analyze up to 384 samples ...
GOAT ANTI CARICA PAPAYA PAPAIN...
Biology Products: